WORKHORSE GROUP 24 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors with Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against
- Wall Street ekes out gains to close languid week
- 'Faster than Porsche but Safer than Volvo': Tesla (TSLA) Begins Model S Plaid Deliveries, Priced Between $131,100 and $145,600
- Oil hits multi-year highs in third weekly gain on demand recovery
- Snowflake (SNOW) Falls Following Investor Day Despite Strong Guidance, Analysts Bullish But Say Investors May Have Wanted More
- Dollar looks stronger as euro and sterling dip
Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.
NEW ORLEANS, May 6, 2021 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have only until May 7, 2021 to file lead plaintiff applications in a securities class action lawsuit against Workhorse Group, Inc. (NasdaqGS: WKHS), if they purchased the Company's securities between July 7, 2020 and February 23, 2021, inclusive (the "Class Period"). This action is pending in the United States District Court for the Central District of California.
What You May Do
If you purchased securities of Workhorse and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email (email@example.com), or visit https://www.ksfcounsel.com/cases/nasdaqgs-wkhs/ https://www.ksfcounsel.com/cases/nyse-pen/ to learn more. If you wish to serve as a lead plaintiff in this class action by overseeing lead counsel with the goal of obtaining a fair and just resolution, you must request this position by application to the Court by May 7, 2021.
About the Lawsuit
Workhorse and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws. On February 23, 2021, the United States Postal Service issued a press release announcing that Oshkosh Defense, not the Company, had been awarded the multibillion-dollar service contract for its Next Generation Delivery Vehicle ("NGDV") project to modernize its postal delivery fleet. On this news, shares of Workhorse fell $14.88 per share, or 47%, to close at $16.47 per share on February 23, 2021.
The case is Farrar v. Workhorse Group, Inc., et al., 21-cv-02072.
About Kahn Swick & Foti, LLC
KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation's premier boutique securities litigation law firms. KSF serves a variety of clients – including public institutional investors, hedge funds, money managers and retail investors – in seeking to recover investment losses due to corporate fraud and malfeasance by publicly traded companies. KSF has offices in New York, California and Louisiana.
To learn more about KSF, you may visit www.ksfcounsel.com.
Kahn Swick & Foti, LLCLewis Kahn, Managing Partnerlewis.firstname.lastname@example.org 1-877-515-18501100 Poydras St., Suite 3200New Orleans, LA 70163
View original content to download multimedia:http://www.prnewswire.com/news-releases/workhorse-group-24-hour-deadline-alert-former-louisiana-attorney-general-and-kahn-swick--foti-llc-remind-investors-with-losses-in-excess-of-100-000-of-deadline-in-class-action-lawsuit-against-workhorse-group-inc---wkhs-301286305.html
SOURCE Kahn Swick & Foti, LLC
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Marcus Ericsson, Honda Win Opening Round of Detroit Doubleheader
- European Hematology Association- First-Line Ibrutinib + Venetoclax Is Superior to Chlorambucil + Obinutuzumab for Chronic Lymphocytic Leukemia/Small Lymphocyte Lymphoma
- Janssen Announces Results from Phase 3 MAIA Study Showing Significant Overall Survival Benefits for Treatment with DARZALEX® (daratumumab) in Patients with Newly Diagnosed Multiple Myeloma Who are Tr
Create E-mail Alert Related CategoriesPRNewswire, Press Releases
Related EntitiesHedge Funds
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!